These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 15899565

  • 1. Oral fluid collection: the neglected variable in oral fluid testing.
    Crouch DJ.
    Forensic Sci Int; 2005 Jun 10; 150(2-3):165-73. PubMed ID: 15899565
    [Abstract] [Full Text] [Related]

  • 2. Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes.
    Ventura M, Pichini S, Ventura R, Leal S, Zuccaro P, Pacifici R, de la Torre R.
    Ther Drug Monit; 2009 Apr 10; 31(2):277-80. PubMed ID: 19307939
    [Abstract] [Full Text] [Related]

  • 3. Introduction and review of collection techniques and applications of drug testing of oral fluid.
    Drummer OH.
    Ther Drug Monit; 2008 Apr 10; 30(2):203-6. PubMed ID: 18367981
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ, Walsh JM, Cangianelli L, Quintela O.
    Ther Drug Monit; 2008 Apr 10; 30(2):188-95. PubMed ID: 18367979
    [Abstract] [Full Text] [Related]

  • 6. Stability of Delta(9)-tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device.
    Moore C, Vincent M, Rana S, Coulter C, Agrawal A, Soares J.
    Forensic Sci Int; 2006 Dec 20; 164(2-3):126-30. PubMed ID: 16423482
    [Abstract] [Full Text] [Related]

  • 7. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM.
    Forensic Sci Int; 2008 Jan 30; 174(2-3):111-9. PubMed ID: 17434274
    [Abstract] [Full Text] [Related]

  • 8. Legal issues in oral fluid testing.
    Kadehjian L.
    Forensic Sci Int; 2005 Jun 10; 150(2-3):151-60. PubMed ID: 15944055
    [Abstract] [Full Text] [Related]

  • 9. The effects of collection methods on oral fluid codeine concentrations.
    O'Neal CL, Crouch DJ, Rollins DE, Fatah AA.
    J Anal Toxicol; 2000 Oct 10; 24(7):536-42. PubMed ID: 11043656
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the Cozart DDSV test for cannabis in oral fluid.
    Kintz P, Brunet B, Muller JF, Serra W, Villain M, Cirimele V, Mura P.
    Ther Drug Monit; 2009 Feb 10; 31(1):131-4. PubMed ID: 19155965
    [Abstract] [Full Text] [Related]

  • 11. Development and validation of the Cozart DDS oral fluid collection device.
    Speedy T, Baldwin D, Jowett G, Gallina M, Jehanli A.
    Forensic Sci Int; 2007 Aug 06; 170(2-3):117-20. PubMed ID: 17624706
    [Abstract] [Full Text] [Related]

  • 12. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V, Lund HM, Andresen W, Gjerde H, Ikdahl SE, Christophersen AS, Øiestad EL.
    Forensic Sci Int; 2012 Jun 10; 219(1-3):165-71. PubMed ID: 22284072
    [Abstract] [Full Text] [Related]

  • 13. [Analysis on the abused drugs in saliva and correlation of saliva drugs concentrations with blood concentrations].
    Li PW, Wang YJ, Liu JF.
    Fa Yi Xue Za Zhi; 2007 Aug 10; 23(4):309-11, 315. PubMed ID: 17896529
    [Abstract] [Full Text] [Related]

  • 14. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL, Barnes AJ, Kim I, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA.
    Forensic Sci Int; 2004 Apr 20; 141(1):41-8. PubMed ID: 15066713
    [Abstract] [Full Text] [Related]

  • 15. The recovery of illicit drugs from oral fluid sampling devices.
    Dickson S, Park A, Nolan S, Kenworthy S, Nicholson C, Midgley J, Pinfold R, Hampton S.
    Forensic Sci Int; 2007 Jan 05; 165(1):78-84. PubMed ID: 16621382
    [Abstract] [Full Text] [Related]

  • 16. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
    Wille SM, Raes E, Lillsunde P, Gunnar T, Laloup M, Samyn N, Christophersen AS, Moeller MR, Hammer KP, Verstraete AG.
    Ther Drug Monit; 2009 Aug 05; 31(4):511-9. PubMed ID: 19571773
    [Abstract] [Full Text] [Related]

  • 17. Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis.
    Lund HM, Øiestad EL, Gjerde H, Christophersen AS.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov 15; 879(30):3367-77. PubMed ID: 21962269
    [Abstract] [Full Text] [Related]

  • 18. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR.
    Ann Clin Biochem; 2011 Nov 15; 48(Pt 6):531-41. PubMed ID: 21885472
    [Abstract] [Full Text] [Related]

  • 19. Stability studies of principal illicit drugs in oral fluid: preparation of reference materials for external quality assessment schemes.
    Ventura M, Pichini S, Ventura R, Zuccaro P, Pacifici R, de la Torre R.
    Ther Drug Monit; 2007 Oct 15; 29(5):662-5. PubMed ID: 17898661
    [Abstract] [Full Text] [Related]

  • 20. Pre-analytical stability of selected benzodiazepines on a polymeric oral fluid sampling device.
    Kempf J, Wuske T, Schubert R, Weinmann W.
    Forensic Sci Int; 2009 Apr 15; 186(1-3):81-5. PubMed ID: 19282117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.